Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Gene Expression of Rnap Ii, Jbp1 and Jbp2 in Leishmania Major Exposed to Antimonials, Amphotericin B and Paromomycin
Seyed Ebrahim Eskandari
Seyed Ebrahim Eskandari

Assistant Professor of Medical Parasitology

Center for Research and Training in Skin Disease and Leprosy

Tehran University of Medical Sciences

All Documents
1. Formulation, in Vitro Evaluation and Therapeutic Effect of Chitosan Coated Pluronic F127 Micelles Containing Miltefosine for the Treatment of Visceral Leishmaniasis in Domestic Dogs Naturally Infected by Leishmania Infantum, Research in Veterinary Science (2025)
2. The Potential Role of Probiotics and Their Bioactive Compounds in the Management of Pulmonary Tuberculosis, Journal of Infection and Public Health (2025)
3. Molecular Diagnosis of Human Cutaneous Leishmaniasis and Identification of the Causative Leishmania Species in Iran: A Narrative Review, Iranian biomedical journal (2024)
4. Photobiomodulation Therapy for Improvement of Body Contour: A Retrospective Study on Middle Eastern Participants, Iranian Journal of Public Health (2024)
5. The Impact of Abo Blood Types on Humoral Immunity Responses and Antibody Persistency After Different Covid-19 Vaccine Regimens, Journal of Medical Virology (2024)
6. Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination With Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2023)
7. Efficacy of Intra-Lesional Injections of Meglumine Antimoniate Once a Week Vs. Twice a Week in the Treatment of Cutaneous Leishmaniasis Caused by L. Tropica in Iran: A Randomized Controlled Clinical Trial, PLoS Neglected Tropical Diseases (2022)
8. Pilot Study of Safety and Efficacy of Topical Liposomal Amphotericin B for Cutaneous Leishmaniasis Caused by Leishmania Major in Islamic Republic of Iran; [Etude Pilote Sur L'innocuite Et L'efficacite De L'amphotericine B Liposomale Topique Pour Le Traitement De La Leishmaniose Cutanee Causee Par Leishmania Major En Republique Islamique D'iran], Eastern Mediterranean Health Journal (2022)
9. Combination of Topical Liposomal Amphotericin B and Glucantime in Comparison With Glucantime Alone for the Treatment of Anthroponotic Cutaneous Leishmaniasis (Acl) Caused by Leishmania Tropica: Study Protocol for a Randomized, Controlled Trial, Iranian Journal of Microbiology (2021)
10. Immune Responses in Cutaneous Leishmaniasis: In Vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania Major, Journal of Arthropod-Borne Diseases (2021)
11. Old World Cutaneous Leishmaniasis in Iran: Clinical Variants and Treatments, Journal of Dermatological Treatment (2021)
12. Immune Response in Cutaneous Leishmaniasis Patients With Healing Vs. Non-Healing Lesions, Iranian Journal of Microbiology (2020)
13. Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (Sinaampholeish) on Healthy Volunteers: Phase I Clinical Trial, Iranian Journal of Parasitology (2019)
14. Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model As a Candidate for Treatment of Cutaneous Leishmaniasis, Journal of Arthropod-Borne Diseases (2018)
15. Anti Leishmania Activity of Lucilia Sericata and Calliphora Vicina Maggots in Laboratory Models, Experimental Parasitology (2016)